Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations

[1]  P. Elliott,et al.  Depression in Rural Communities and Primary Care Clinics in Chiapas, Mexico , 2019, Journal of epidemiology and global health.

[2]  K. Eggan,et al.  Culturing human pluripotent stem cells from diverse culture histories , 2017 .

[3]  L. Laurent,et al.  Spontaneous Single‐Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival , 2016, Stem cells.

[4]  Miguel A. Juárez,et al.  Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells , 2016, Stem cell reports.

[5]  Dmitriy Sonkin,et al.  TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data , 2016, Human mutation.

[6]  Patrick F. Sullivan,et al.  Ultra-rare disruptive and damaging mutations influence educational attainment in the general population , 2016, Nature Neuroscience.

[7]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[8]  P. Campbell,et al.  Somatic mutation in cancer and normal cells , 2015, Science.

[9]  K. Garber.  RIKEN suspends first clinical trial involving induced pluripotent stem cells , 2015, Nature Biotechnology.

[10]  James A. Gagnon,et al.  Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. , 2015, Cell reports.

[11]  P. Rosenfeld,et al.  Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies , 2015, The Lancet.

[12]  J. Bazile,et al.  Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi , 2015, Journal of the International AIDS Society.

[13]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[14]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[15]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[16]  Graham Thornicroft,et al.  Including mental health among the new sustainable development goals , 2014, BMJ : British Medical Journal.

[17]  L. Pachter,et al.  Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem Cells , 2014, Stem cell reports.

[18]  Xiaolin Zhou,et al.  Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations , 2014, Scientific Reports.

[19]  C. Spits,et al.  Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL. , 2014, Molecular human reproduction.

[20]  G. Freedman,et al.  Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 , 2013, PLoS medicine.

[21]  R. Lothe,et al.  BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures , 2013, Stem cell reports.

[22]  J. Sachs,et al.  1 million community health workers in sub-Saharan Africa by 2015 , 2013, The Lancet.

[23]  J. Mukherjee,et al.  Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Jonathan Schug,et al.  Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. , 2013, Cell stem cell.

[25]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[26]  G. Abecasis,et al.  Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data. , 2012, American journal of human genetics.

[27]  T. Ravindran.  Universal access: making health systems work for women , 2012, BMC Public Health.

[28]  M. Medina-Mora,et al.  Depression, gender, and the treatment gap in Mexico. , 2012, Journal of affective disorders.

[29]  M. Medina-Mora,et al.  Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis , 2012, BMJ : British Medical Journal.

[30]  G. Heinze,et al.  Los especialistas en psiquiatría en México: su distribución, ejercicio profesional y certificación , 2012 .

[31]  Dong Ryul Lee,et al.  Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage , 2011, Nature Biotechnology.

[32]  Jeff Mellen,et al.  High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number , 2011, Analytical chemistry.

[33]  Syed Haider,et al.  International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data , 2011, Database J. Biol. Databases Curation.

[34]  Jennifer M. Bolin,et al.  Chemically defined conditions for human iPS cell derivation and culture , 2011, Nature Methods.

[35]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[36]  A. Schene,et al.  Measurement invariance with respect to ethnicity of the Patient Health Questionnaire-9 (PHQ-9). , 2011, Journal of affective disorders.

[37]  Ryan A. Flynn,et al.  A unique chromatin signature uncovers early developmental enhancers in humans , 2011, Nature.

[38]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[39]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[40]  D. Malkin.  Li-fraumeni syndrome. , 2001, Genes & cancer.

[41]  N. Ford,et al.  Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care , 2010, Tropical medicine & international health : TM & IH.

[42]  Galt P. Barber,et al.  BigWig and BigBed: enabling browsing of large distributed datasets , 2010, Bioinform..

[43]  A. Efron,et al.  Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy , 2010, AIDS.

[44]  David Kessler,et al.  Concordance between PHQ-9 scores and patients' experiences of depression: a mixed methods study. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[45]  Manuel Serrano,et al.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.

[46]  K. Kroenke,et al.  Validity/Reliability of PHQ-9 and PHQ-2 Depression Scales Among Adults Living with HIV/AIDS in Western Kenya , 2009, Journal of General Internal Medicine.

[47]  Xiaolei Yin,et al.  Two supporting factors greatly improve the efficiency of human iPSC generation. , 2008, Cell stem cell.

[48]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[49]  Heli Skottman,et al.  Good manufacturing practice and clinical-grade human embryonic stem cell lines. , 2008, Human molecular genetics.

[50]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[51]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[52]  O. O. Afolabi,et al.  Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. , 2006, Journal of affective disorders.

[53]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.

[54]  Xinbin Chen,et al.  Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes , 2004, Oncogene.

[55]  T. Peters,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[56]  Liliana Mondragón,et al.  Seguimiento a dos años de una intervención psicoeducativa para mujeres con síntomas de depresión, en servicios de salud para población abierta , 2003 .

[57]  L. Mondragón,et al.  Outcome results of two levels of intervention in low-income women with depressive symptoms. , 2003, The American journal of orthopsychiatry.

[58]  W. Katon,et al.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. , 2001, The American journal of psychiatry.

[59]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[60]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[61]  W. Katon,et al.  Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. , 1999, Archives of general psychiatry.

[62]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[63]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.